Blossomhill Therapeutics, Inc. (BLSM)

26.80 +1.06 (+4.12%) USD  |  NASDAQ  |  Sep 21, 16:00
26.13 -0.67 (-2.50%) After-Hours: 20:00
More

Blossomhill Therapeutics Net Income (Quarterly) : -23.76M for June 30, 2026

Net Income (Quarterly) Chart

View Net Income (Quarterly) for BLSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -23.76M
March 31, 2026 -21.01M
Date Value
June 30, 2025 -13.24M
March 31, 2025 -10.48M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. -2.936M
Cocrystal Pharma, Inc. -3.164M
CNBX Pharmaceuticals, Inc. -0.1542M
GB Sciences, Inc. --
Arvinas, Inc. 169.40M

Net Income (Quarterly) Related Metrics

Total Expenses (Quarterly) 23.76M
EPS Diluted (Quarterly) -0.7475
Enterprise Value 1.037B
Earnings Yield -8.04%
Normalized Earnings Yield -8.040